Table 1 Antibodies used
From: Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases
Name of antibody | Protein target | Manufacturer | Catalog | Dilution used |
|---|---|---|---|---|
CK7 | Cytokeratin 7 | Fuzhou Maixin Biotech | Kit-0021 | 1:1 |
P504S | alpha-methylacyl-CoA racemase (AMACR), P504S | Fuzhou Maixin Biotech | RMA-0546 | 1:1 |
WT-1 | Wilms tumor 1 | Fuzhou Maixin Biotech | MAB-0678 | 1:1 |
CD57 | human natural killer-1 | Fuzhou Maixin Biotech | MAB-0257 | 1:1 |
P53 | p53 | Fuzhou Maixin Biotech | MAB-0674 | 1:1 |
BCL2 | B-cell lymphoma 2 | Fuzhou Maixin Biotech | RMA-0660 | 1:1 |
CCND1 | Cyclin-D1 | Abcam | ab16663 | 1:200 |
P16 | P16INK4A | Fuzhou Maixin Biotech | MAB-0673 | 1:1 |
p-ERK | phosphorylated Thr202/Tyr204-p44/42 MAPK | Cell Signaling Tech | 4370 | 1:100 |
ERK | total p44/42 MAPK | Cell Signaling Tech | 4695 | 1:100 |
p-MEK | phosphorylated MEK1/2 (Ser221) | Cell Signaling Tech | 2338 | 1:100 |
MEK | total MEK1/2 | Cell Signaling Tech | 4694 | 1:100 |
DUSP4/MKP-2 | Dual specificity protein phosphatase 4/MAP kinase phosphatase-2 | Abcam | ab216576 | 1:50 |
DUSP6/MKP-3 | Dual specificity protein phosphatase 6/MAP kinase phosphatase-3 | Abcam | ab54940 | 1:50 |